Sally Blower, PhD, is Professor of Biomathematics at the David Geffen School of Medicine at UCLA. Previously she has held faculty positions at the University of California, San Francisco, and at the University of California at Berkeley (School of Public Health). She is a mathematical and evolutionary biologist whose research focuses on developing mathematical models of infectious diseases. She received her undergraduate degree from the University of Edinburgh, and her PhD from Stanford University in 1987. The primary focus of her research is to use models as health policy tools. She uses mathematical models: (1) to design epidemic control strategies, (2) to understand and to predict the emergence of antibiotic and antiviral drug resistance, and (3) to develop vaccination strategies. The overall objective of her research is to develop the study of infectious diseases into a predictive science. She has published over 80 research articles mainly focused on HIV, tuberculosis, and genital herpes. She was the first to publish mathematical models for predicting the potential epidemic-level impact of HIV vaccines, the impact of drug-resistant tuberculosis, and the expected impact of drug-resistant HIV in both developing and developed countries. She introduced uncertainty analysis to the field of infectious disease modeling. These innovative methodologies have transformed infectious disease modeling from description to prediction. She has served as a consultant to the CDC, WHO, RAND, EPA, Burroughs Wellcome, GlaxoSmithKline, Aventis Pasteur, the Frankel Group, and the Global HIV Prevention Group.

J. Brooks Jackson, MD, MBA, is Professor and Chairman of Pathology at the Johns Hopkins Medical Institutions. Dr. Jackson is Director of the clinical HIV Laboratory at Johns Hopkins Hospital and has been involved in numerous clinical HIV therapeutic and prevention trials in the United States, Uganda, and China. He is a funded investigator in the NIAID-sponsored adult and pediatric AIDS Clinical Trials Groups and the HIVNET and HIV Prevention Trials Network. Dr. Jackson is the Protocol Chair of several adult and perinatal HIV prevention trials in the United States and Uganda including the HIVNET 012 perinatal nevirapine trial.

Gilbert Kombe, MBBS, MPH, serves as HIV/AIDS senior technical advisor at Partnership for Health Reformplus Project at Abt Associates Inc. In this capacity, he directs technical assistance and provides leadership to regional and country teams in determining achievable and sustainable strategies to strengthen health systems’ capacity to provide effective HIV/AIDS prevention, treatment and care interventions. For many years, Dr. Kombe worked on a number of HIV/AIDS issues including costing and financing of ARVs, designing of service delivery models, and developing national antiretroviral policies in low-resource settings. Recently, he has worked on ARV costing and policy issues in Zambia, Nigeria, and Uganda. Dr. Kombe has worked

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement